Literature DB >> 20113699

ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States?

Olatokunbo M Famakinwa1, Sanziana A Roman, Tracy S Wang, Julie Ann Sosa.   

Abstract

BACKGROUND: The aim of this study was to benchmark national practice patterns against American Thyroid Association guidelines for thyroidectomy, lymphadenectomy, and radioactive iodine (RAI) for differentiated thyroid cancer (DTC).
METHODS: A cross-sectional analysis of patients with DTC in Surveillance, Epidemiology, and End Results was performed. Outcomes were practice accordance with guidelines for extent of surgery and RAI treatment. Predictors of accordance were identified.
RESULTS: A total of 52,964 patients with DTC were included. Seventy-six percent were women, and 83% white. There was 71% accordance with surgery recommendations; among these, 15% underwent central lymphadenectomy, 31% had RAI but no lymphadenectomy, and 25% had RAI and lymphadenectomy. The highest accordance with guidelines was for patients aged <45 years with stage II disease (80%); the lowest accordance was for patients aged > or = 45 years with stage II disease (52%). Patients aged >65 years and of black race had the lowest accordance (P < .001).
CONCLUSIONS: Variation in practice suggests variation in the quality of care for DTC. Greater dissemination of evidence-based recommendations is needed for elderly and minority patients. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20113699     DOI: 10.1016/j.amjsurg.2009.04.022

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  BRAF(V600E) mutation analysis from May-Grünwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma.

Authors:  Aneeta Patel; Joanna Klubo-Gwiezdzinska; Victoria Hoperia; Alexander Larin; Kirk Jensen; Andrew Bauer; Vasyl Vasko
Journal:  Endocr Pathol       Date:  2011-12       Impact factor: 3.943

2.  Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement.

Authors:  Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

3.  Adjuvant radioactive iodine use among differentiated thyroid cancer patients in the military health system.

Authors:  Abegail A Gill; Lindsey Enewold; Shelia H Zahm; Craig D Shriver; Li Zheng; Katherine A McGlynn; Kangmin Zhu
Journal:  Mil Med       Date:  2014-09       Impact factor: 1.437

Review 4.  Thyroid cancer surgery guidelines in an era of de-escalation.

Authors:  K J Kovatch; C W Hoban; A G Shuman
Journal:  Eur J Surg Oncol       Date:  2017-03-16       Impact factor: 4.424

5.  Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities.

Authors:  Archana Radhakrishnan; David Reyes-Gastelum; Paul Abrahamse; Brittany Gay; Sarah T Hawley; Lauren P Wallner; Debbie W Chen; Ann S Hamilton; Kevin C Ward; Megan R Haymart
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 6.134

6.  Limited adequacy of thyroid cancer patient follow-up at a Canadian tertiary care centre.

Authors:  Elaine Lam; Scott S Strugnell; Chris Bajdik; Daniel Holmes; Sam M Wiseman
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

7.  National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.

Authors:  Eun Hae Estelle Chang; Waseem Lutfi; Joseph Feinglass; Alexandra Eudokia Reiher; Tricia Moo-Young; Mihir Kiran Bhayani
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

Review 8.  ACTIVE SURVEILLANCE FOR PAPILLARY THYROID MICROCARCINOMA: NEW CHALLENGES AND OPPORTUNITIES FOR THE HEALTH CARE SYSTEM.

Authors:  Grace C Haser; R Michael Tuttle; Henry K Su; Eran E Alon; Donald Bergman; Victor Bernet; Elise Brett; Rhoda Cobin; Eliza H Dewey; Gerard Doherty; Laura L Dos Reis; Jeffrey Harris; Joshua Klopper; Stephanie L Lee; Robert A Levine; Stephen J Lepore; Ilya Likhterov; Mark A Lupo; Josef Machac; Jeffrey I Mechanick; Saral Mehra; Mira Milas; Lisa A Orloff; Gregory Randolph; Tracey A Revenson; Katherine J Roberts; Douglas S Ross; Meghan E Rowe; Robert C Smallridge; David Terris; Ralph P Tufano; Mark L Urken
Journal:  Endocr Pract       Date:  2016-01-22       Impact factor: 3.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.